Editas Medicine awarded Chief Medical Officer Ory Daniel Scott 950,000 derivative securities on 2026-09-08. The award equals 100.0% of Scott’s resulting derivative-securities holding, so the full reported holding follows this transaction and is classified as an award under transaction code A.

Key Highlights

  • Ory Daniel Scott’s resulting derivative-securities holding was 950,000.
  • The transaction was recorded under code A.
  • The award represented about 100.0% of Scott’s resulting derivative-securities holding.

Editas Medicine, Inc. (NASDAQ: EDIT) awarded 950,000 derivative securities to Ory Daniel Scott, its executive vice president and chief medical officer. The transaction was recorded on 8 September 2026. Scott’s resulting derivative-securities holding was also 950,000.

Award Details and Resulting Holding

The transaction carries code A. Following the transaction, Scott’s holding stood at 950,000 derivative securities.

What the 100.0% Holding Represents

The award accounted for about 100.0% of Scott’s resulting derivative-securities holding. The percentage describes the award’s share of the resulting holding.